| Product Code: ETC11380459 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Sweden`s anti-rheumatics import market continued to see steady growth with a CAGR of 4.69% from 2020 to 2024. The top exporting countries to Sweden for anti-rheumatics in 2024 were Denmark, Belgium, Germany, Netherlands, and Italy. Despite the strong growth rate of 17.54% from 2023 to 2024, the market concentration, as measured by the HHI, remained low, indicating a competitive landscape among the exporting countries. This suggests a diverse and competitive market environment for anti-rheumatics imports in Sweden.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Anti Rheumatics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Anti Rheumatics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Anti Rheumatics Market - Industry Life Cycle |
3.4 Sweden Anti Rheumatics Market - Porter's Five Forces |
3.5 Sweden Anti Rheumatics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Anti Rheumatics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Sweden Anti Rheumatics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Sweden Anti Rheumatics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Anti Rheumatics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rheumatic diseases in Sweden |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of rheumatic conditions |
4.2.3 Advancements in research leading to the development of innovative anti-rheumatic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of anti-rheumatic drugs in Sweden |
4.3.2 High cost associated with some of the advanced anti-rheumatic treatments |
4.3.3 Potential side effects and safety concerns of certain anti-rheumatic medications |
5 Sweden Anti Rheumatics Market Trends |
6 Sweden Anti Rheumatics Market, By Types |
6.1 Sweden Anti Rheumatics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Anti Rheumatics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Sweden Anti Rheumatics Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Sweden Anti Rheumatics Market Revenues & Volume, By DMARDs, 2021 - 2031F |
6.1.5 Sweden Anti Rheumatics Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.2 Sweden Anti Rheumatics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Anti Rheumatics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Sweden Anti Rheumatics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Sweden Anti Rheumatics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Sweden Anti Rheumatics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Sweden Anti Rheumatics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Sweden Anti Rheumatics Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Sweden Anti Rheumatics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Sweden Anti Rheumatics Market Revenues & Volume, By Retail, 2021 - 2031F |
6.4.3 Sweden Anti Rheumatics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4.4 Sweden Anti Rheumatics Market Revenues & Volume, By Online, 2021 - 2031F |
7 Sweden Anti Rheumatics Market Import-Export Trade Statistics |
7.1 Sweden Anti Rheumatics Market Export to Major Countries |
7.2 Sweden Anti Rheumatics Market Imports from Major Countries |
8 Sweden Anti Rheumatics Market Key Performance Indicators |
8.1 Average time from symptom onset to treatment initiation for rheumatic patients in Sweden |
8.2 Patient adherence rate to prescribed anti-rheumatic medications |
8.3 Number of clinical trials conducted for new anti-rheumatic therapies in Sweden |
8.4 Patient-reported outcomes measures improvement after anti-rheumatic treatment |
8.5 Rate of hospitalizations due to uncontrolled rheumatic diseases |
9 Sweden Anti Rheumatics Market - Opportunity Assessment |
9.1 Sweden Anti Rheumatics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Anti Rheumatics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Sweden Anti Rheumatics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Sweden Anti Rheumatics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Anti Rheumatics Market - Competitive Landscape |
10.1 Sweden Anti Rheumatics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Anti Rheumatics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |